BioBrit — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Procisedxprocisedx.cominJul 2020
ProciseDx develops diagnostic technology, including a point-of-care testing platform, drawing on expertise in central lab instrumentation and point-of-care devices.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Larry Mimms(Executive Officer, Director)Magda Marquet(Director)Martin Hendrix(Director)Larry Abensur(Director)Peter Westlake(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.